(PDF) P2.15-09 the Impact of Treatment Evolution in NSCLC

P2.15-09 the Impact of Treatment Evolution in NSCLC (iTEN) Model: Survival and Cost of Treating Patients With Advanced NSCLC in 2017

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1450

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

MA18.02 the Impact of Treatment Evolution in NSCLC (iTEN) Model: Development and Validation

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.15-16 Clinical Economic Impact of Improved Genotyping in Patients With Advanced Non-Small Cell Lung Adenocarcinoma (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

Pcn86 - Validation of the Impact of Treatment Evolution in Non-Small Cell Lung Cancer (Nsclc) Model (Iten): A Discrete Event Patient Simulation

Value in Health

Occupational Health

English

P2.15-18 Cost-Effectiveness Analysis of Second-Line Immune Checkpoint Inhibitors for Advanced NSCLC in Colombia

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.17-09 Retrospective Analysis of the Efficacy and Safety of Multimodal Treatment for Locally-Advanced NSCLC in Elderly Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-09 Impact of Urban or Rural Residence on Overall Survival for Patients With Metastatic Non-Squamous NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.15-31 the Evolution of Costs in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Ontario, Canada Between 1999 to 2014

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-04 Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

Cost Analysis of the Management of Brain Metastases in Patients With Advanced ALK+ NSCLC: Alectinib Versus Crizotinib

Lung Cancer Management

English